Log in to save to my catalogue

Oncology - Basal Cell Cancer; Reports on Basal Cell Cancer Findings from D. Odom and Co-Researchers...

Oncology - Basal Cell Cancer; Reports on Basal Cell Cancer Findings from D. Odom and Co-Researchers...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1912416263

Oncology - Basal Cell Cancer; Reports on Basal Cell Cancer Findings from D. Odom and Co-Researchers Provide New Insights (A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma)

About this item

Full title

Oncology - Basal Cell Cancer; Reports on Basal Cell Cancer Findings from D. Odom and Co-Researchers Provide New Insights (A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma)

Publisher

Atlanta: NewsRx

Journal title

Medical Devices & Surgical Technology Week, 2017, p.871

Language

English

Publication information

Publisher

Atlanta: NewsRx

More information

Scope and Contents

Contents

According to news reporting originating in Research Triangle Park, North Carolina, by NewsRx journalists, research stated, "Based on single-arm trial data (BOLT), sonidegib was approved in the US and EU to treat locally advanced basal cell carcinomas (BCCs) ineligible for curative surgery or radiotherapy. According to the news reporters, the...

Alternative Titles

Full title

Oncology - Basal Cell Cancer; Reports on Basal Cell Cancer Findings from D. Odom and Co-Researchers Provide New Insights (A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_1912416263

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1912416263

Other Identifiers

ISSN

1537-1409

E-ISSN

1537-1417

How to access this item